Enanta Pharmaceuticals, Inc. revenue breakdown overview

Enanta Pharmaceuticals, Inc. revenue for the last year amounted to 67.64 M USD, the most of which — 79.20 M USD — came from its highest performing source at the moment, Small Molecule Drugs, the year earlier bringing 86.16 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Enanta Pharmaceuticals, Inc. 79.20 M USD, and the year before that — 86.16 M USD.